<DOC>
	<DOCNO>NCT01144650</DOCNO>
	<brief_summary>The main purpose study get information safety efficacy treatment Dapsone prevent disability ischemic Stroke , patient diagnose anterior territory brain infarct .</brief_summary>
	<brief_title>Dapsone Acute Ischemia Stroke Study</brief_title>
	<detailed_description>Cerebrovascular disease third cause mortality around world . Seventy-five percent case correspond ischemic stroke , remain 25 % hemorrhagic infarct . The social impact Stroke high first cause disability . After Stroke , several mechanism secondary damage act spread damage surround tissue . Those mechanisms include : 1 ) Excitotoxicity excitatory amino acid ' release 2 ) Overproduction free radical 3 ) Exacerbated inflammatory response 4 ) Apoptosis . Many neuroprotective strategy test cope already mention damage process poor clinical result . Many clinical trial fail provide neuroprotection patient acute stroke . Then , need safe drug clinical efficacy prevent Stroke disability consequence highly recognize . Dapsone safe relatively free adverse reaction , propose clinical trial ass safety efficacy use drug patient ischemic brain stroke . Methods : A double-blind , placebo-controlled , randomized clinical trial dapsone conduct 2009 2010 . Three-hundred patient CT MRI document ischemic stroke anterior cerebral territory include . Patients 4 20 point National Institute Health Stroke Scale ( NIHSS ) randomly allocate receive either single total dose 250 mg dapsone placebo within first 12 h stroke . For follow-up , NIHSS day 0 , 2 , 7 , 30 , 60 90 , modify Rankin scale ( mRS ) day 0 , 30 , 60 90 , Barthel index ( BI ) day 90 , apply . Adverse reaction also record . The Primary clinical outcome patient assess 90 day stroke obtain shift analysis baseline level scale mRS NIHSS . Secondary clinical outcome BI day 90 . An interim analysis data perform study recruit one-hundred patient . Statistical analysis perform intention-to-treat approach .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Patients clinical diagnosis acute cerebrovascular event anterior cerebral territory , within last 12 hour match MRI axial CT image . Patients 4 point National Institute Health Stroke Scale ( NIHSS ) Age old 18 year , gender Non acute cerebrovascular event previous Informed consent sign patient relative Diagnosed recurrent disease like : heart failure ; Myocardial Infarction 8 week ; ventrivular arrhythmia diagnose ECG ; SecondDegree ThirdDegree Atrioventricular Block ; Long QT Syndrome . Pregnancy Allergic reaction sulfa medication Patients kidney failure hepatic insufficiency Deficiency glucose6phosphate dehydrogenase diagnose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Dapsone</keyword>
	<keyword>Cerebrovascular Accident , Acute</keyword>
	<keyword>Neuroprotection</keyword>
</DOC>